Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?

被引：0
|
作者：
Robert Marcec
Robert Likic
机构：
[1] University of Zagreb,School of Medicine
[2] University Hospital Centre Zagreb,Unit for Clinical Pharmacology, Department of Internal Medicine
来源：
Clinical Pharmacokinetics | 2022年 / 61卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1321 / 1323
页数：2
相关论文
共 50 条
  • [1] Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?
    Marcec, Robert
    Likic, Robert
    [J]. CLINICAL PHARMACOKINETICS, 2022, 61 (09) : 1321 - 1323
  • [2] The COVID-19 outbreak and de-escalation of thyroid cancer diagnosis and treatment
    Giorgio Grani
    Laura Ciotti
    Valeria Del Gatto
    Teresa Montesano
    Marco Biffoni
    Laura Giacomelli
    Marialuisa Sponziello
    Valeria Pecce
    Piernatale Lucia
    Antonella Verrienti
    Sebastiano Filetti
    Cosimo Durante
    [J]. Endocrine, 2022, 78 : 387 - 391
  • [3] The COVID-19 outbreak and de-escalation of thyroid cancer diagnosis and treatment
    Grani, Giorgio
    Ciotti, Laura
    Del Gatto, Valeria
    Montesano, Teresa
    Biffoni, Marco
    Giacomelli, Laura
    Sponziello, Marialuisa
    Pecce, Valeria
    Lucia, Piernatale
    Verrienti, Antonella
    Filetti, Sebastiano
    Durante, Cosimo
    [J]. ENDOCRINE, 2022, 78 (02) : 387 - 391
  • [4] Impact of COVID-19 during de-escalation in pediatric urology
    Bujons Tur, Anna
    Gomez Fraile, Andres
    Lopez Pereira, Pedro
    Serrano, Agustin
    [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2020, 73 (05): : 455 - 462
  • [5] Escalation and de-escalation concept for intensive care beds in hospitals reserved for COVID-19
    Pfenninger, E. G.
    Faust, J-O.
    Klingler, W.
    Fessel, W.
    Schindler, S.
    Kaisers, U. X.
    [J]. ANAESTHESIST, 2022, 71 (01): : 12 - 20
  • [6] The need for a steroid de-escalation pathway during the covid-19 pandemic
    Li, A. P. Z.
    Mustafa, O. G.
    Harris, S. M.
    [J]. DIABETIC MEDICINE, 2021, 38
  • [7] THE DE-ESCALATION IN UROLOGY. RECOMMENDATIONS FOR ACTION IN THE COVID-19 PANDEMIC
    Lopez-Fond, Luis
    [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2020, 73 (05): : 325 - 327
  • [8] Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    [J]. INFECTION AND CHEMOTHERAPY, 2022, 54 (02): : 369 - 369
  • [9] Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open
    Sands, Bruce E.
    Armuzzi, Alessandro
    Marshall, John K.
    Lindsay, James O.
    Sandborn, William J.
    Danese, Silvio
    Panes, Julian
    Bressler, Brian
    Colombel, Jean-Frederic
    Lawendy, Nervin
    Maller, Eric
    Zhang, Haiying
    Chan, Gary
    Salese, Leonardo
    Tsilkos, Konstantinos
    Marren, Amy
    Su, Chinyu
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (02) : 271 - 280
  • [10] Management of breast cancer surgery during de-escalation of COVID-19 infection.
    Brenes Sanchez, Juana Maria
    Lopez Picado, Amanda
    Olivares Crespo, Maria Eugenia
    Garcia Saenz, Jose Angel
    De La Plata Merlo, Rosa Maria
    Herrera De La Muela, Maria
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (18)
12345